Saturday, 31 October 2026European Markets

AUGROS COSMETICS Stock Bullish By 15% So Far On Tuesday

Loading stream...

on tuesday, augros cosmetics (augr.pa) saw its stock rise 15.56% to eur7.80 after experiencing five consecutive sessions of losses. meanwhile, the cac 40 index experienced a decrease of 1.35% to eur7,220.92, following two straight sessions of gains. this recent activities has sparked a buzz in the stock market, given the volatility experienced.

company profile

france-based augros cosmetics specializes in customized packaging solutions for perfume, cosmetic and spirit industries. despite the current negative market sentiment, their stock price has seen a marked rebound - showing their resilience when facing downturns in market trends.

the numbers at a glance

the trailing twelve months earnings per share (eps) for this company totaled eur0.43, while their price to earnings ratio (per) currently stands at 18.14. this suggests investors are paying eur18.14 per euro of annual earnings and hints at a relatively high valuation.

stock market indicators

according to the stochastic oscillator, a tool often used in technical analysis to signal overbought and oversold conditions, augros cosmetics' stock is considered overbought. this means its shares are trading above their true value and could potentially see corrective price action.

volatility in the market

recently, augros cosmetics has experienced significant volatility. their last week intraday variation average was negative 4.99%, while over the past month, it has averaged positive 0.02%. these figures indicate the degree of uncertainty or risk associated with large changes to its stock value.

looking ahead

augros cosmetics' ability to rebound indicates strong prospective performance despite market challenges. however, investors should keep an eye on its high valuation and overbought condition. this state may signal a potential market correction down the road.

more news about augros cosmetics (augr.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
AUGROS COSMETICS Stock Bullish By 15% So Far On Tuesday | ViaNews EU